• IgNova Files Patent Application on Antibody Against COVID-19 americanpharmaceuticalreview
    July 03, 2020
    IgNova has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY).
PharmaSources Customer Service